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Primary sucrase-isomaltase deficiency, originally thought to be a homozygous recessive disorder, has been found
to have numerous genetic variants that alone or in combination (compound heterozygosity) express varying
degrees of clinical illness, most commonly causing chronic diarrhea, abdominal pain, and bloating. These
symptoms are also present with secondary sucrase-isomaltase deficiency. Recent investigations are providing
evidence that sucrase-isomaltase deficiency is more prevalent and of greater clinical significance than previously
suspected. Further research is required to correlate the specific genotypes and phenotypes with their clinical
expressions and to determine the most appropriate treatment algorithm for these patients.
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Introduction
The linked disaccharidase, sucrase-isomaltase, is a glyco-
protein localized to the brush border membrane of small
intestinal villi. Sucrase-isomaltase is synthesized and as-
sembled in the rough endoplasmic reticulum as a homolo-
gous pro-enzyme dimer which passes through the Golgi
apparatus and is transported to the apical cell surface of
villi [1]. There, it is cleaved into its mature subunits, su-
crase and isomaltase, by pancreatic proteases. Isomaltase
cleaves branched (1–6 linked) α-limit dextrins, while su-
crase digests sucrose, maltose, short 1–4 linked glucose
oligomers, and some branched starches into sugar mono-
mers for intestinal absorption, its activity often overlapping
with maltase-glucoamylase [2]. The cleaved monosaccha-
rides are then transported across the epithelial brush
border for absorption and metabolism. Sucrase is an indu-
cible enzyme in early development, such that increased ex-




The first report of an autosomal recessive disaccharidase
deficiency was congenital sucrase-isomaltase deficiency
(CSID) in 1960 [8]. The affected children presented with
osmotic diarrhea, mild steatorrhea, chronic diarrhea, irrit-
ability, and vomiting after consuming sucrose [9]. The dif-
ficulty in providing adequate nutrition to these patients
can lead to dehydration, metabolic acidosis, hypercalce-
mia, failure to thrive, and developmental delay. CSID was
originally believed to be rare, occurring primarily among
the native population of Alaska and Greenland [10, 11]. A
trafficking defect with intracellular accumulation of pro-
sucrase-isomaltase in the Golgi apparatus was found to be
responsible [1].
Genetic factors
Since the discovery of the initial trafficking error, other
phenotypes have been discovered [12] and, currently, seven
phenotypes are known [13]. More than 25 mutations
within the human sucrase gene are responsible for these
CSID phenotypes [14]. Some sucrase-isomaltase variants
show classical autosomal recessive homozygous inherit-
ance, while others demonstrate compound heterozygote
inheritance [15]. Sucrase-isomaltase variants can occur on
either sucrase or isomaltase subunits, resulting in varied ef-
fects on sucrase-isomaltase enzyme activity [16].
There is now strong evidence that heterozygous carriers
also experience symptoms of CSID, such as chronic diar-
rhea, abdominal pain, and bloating [17]. It is currently esti-
mated that 2–9 % of Americans of European descent may
be affected, suggesting that sucrase-isomaltase deficiency
Correspondence: stancohen@aol.com
Children’s Center for Digestive Health Care, Children’s Healthcare of Atlanta,
993D Johnson Ferry Road NE, Suite 440, Atlanta, GA 30342, USA
© 2016 Cohen. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons
license, and indicate if changes were made.
Cohen Molecular and Cellular Pediatrics  (2016) 3:5 
DOI 10.1186/s40348-015-0028-0
has been greatly underrecognized [17]. Therefore, the
newer term genetic sucrase-isomaltase deficiency (GSID)
should be used to encompass the entire range of inherit-
ance patterns while CSID is reserved to specifically identify
homozygous recessive individuals.
For example, the sucrase-isomaltase variants V577G
and G1073D result in blocked transport in the ER loss of
normal enzyme activity while the sucrase-isomaltase vari-
ant V15F has reduced cell surface expression resulting in
decreased sucrase activity [16]. Analyses at the cellular,
molecular, and functional levels of 11 novel cases with
CSID revealed three categories of sucrase-isomaltase vari-
ants: transport competent, partially transport competent,
and transport incompetent [18]. Patients with all three
variant categories showed reduced or drastically reduced
enzymatic activities of sucrase and isomaltase and symp-
toms resembling irritable bowel syndrome [17].
Secondary or acquired sucrase-isomaltase
deficiency
Available evidence suggests that other forms of chronic
diarrhea share some of the features of GSID and may
represent acquired or secondary forms of sucrase-
isomaltase deficiency. For example, a reduced height of
intestinal villi in pigs is directly correlated with reduced
brush-border enzyme activity, specifically lactase, su-
crase, and maltase [19]. Clinically, the reduced enzym-
atic activity and villous atrophy in the small intestine
are associated with maldigestive and malabsorptive
diarrhea [20]. Numerous human gastrointestinal disor-
ders, such as celiac disease, are also associated with vil-
lous atrophy and diarrhea and may represent secondary
or acquired forms of sucrase-isomaltase deficiency
(Table 1) [21]. In these disorders, the clinical impact of
sucrase-isomaltase deficiency is often transient, with
enzymatic activity gradually returning to normal or
near normal as the underlying disorder is successfully
resolved.
Clinical features
Whether due to a primary (genetic) or secondary (ac-
quired) deficiency, absent or diminished enzyme activity
allows undigested sugars to accumulate in the lumen of
the small intestine, resulting in the clinical effects of
sucrase-isomaltase deficiency [12]. The osmotic effect of
malabsorbed sugars contributes to watery, hyperosmolar
diarrhea. Subsequently, other symptoms are caused by the
fermentation of undigested sucrose by colonic bacterial
microflora which release methane, hydrogen, and carbon
dioxide causing bloating and abdominal pain [22].
Symptom severity becomes a function of residual su-
crase and isomaltase activity, amount of sugar and starch
consumed, extent of buffering by other foods, and gastric
emptying [22]. Frequent diarrhea can be the result and
also the cause of rapid small-bowel transit. The degree of
fermentation of any malabsorbed carbohydrates by the co-
lonic bacteria can also stimulate diarrhea and further
lessen exposure time for existing enzymes to digest sub-
strate [22]. Children are more susceptible to the symp-
toms of sucrase-isomaltase deficiency because the length
of their small intestine is shorter and the reserve capacity
of the colon to absorb excess luminal fluid is reduced [22].
Consequently, symptoms sometimes improve with age.
The current standard for the diagnosis of sucrase-
isomaltase deficiency is to assay duodenal or jejunal mu-
cosa biopsy specimens for lactase, sucrase, isomaltase
(palatinase), and maltase activity [22, 23]. In addition to
the usual histological specimens obtained at the time of
upper endoscopy, several biopsies are sampled from the
distal duodenum or jejunum, immediately frozen and
sent to a laboratory, and assayed for enzyme activity.
The standard assay is the Dahlquist method which incu-
bates the biopsied tissue together with the appropriate
substrate and measures the released glucose. Using this
method, disaccharidase activity in the duodenum can be
almost 40 % less than that in the proximal jejunum [24].
Additionally, the broad effectiveness of SI in digesting
1,4-linkages results in a tight correlation of sucrase ac-
tivity with maltase and isomaltase activity [25].
The invasiveness of obtaining biopsies for disaccharidase
assays has led to the development of surrogate methods,
based on the exhalation of gases produced by the enzym-
atic degradation of the substrate which reflect the clinical
Table 1 Potential causes of secondary or acquired sucrase-
isomaltase deficiency or maldigestion
Villous atrophy or alteration
Celiac disease
Non-tropical sprue















Ulcerative, microscopic, and lymphocytic colitis
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effect of sucrose intolerance. The sucrose hydrogen breath
test is easily performed by having the patient drink a
standard amount of sucrose or 13C-sucrose. The amount
of expired hydrogen or 13C-methane measured in expired
breath correlates well with intestinal enzyme activity [26].
More recently, sucrase-isomaltase exome genetic sequen-
cing has become available for identifying homozygous and
compound heterozygote mutations responsible for genetic
sucrase-isomaltase deficiency [16]. Additionally, dietary
modification and oral enzyme replacement trials using
synthetic sucrase (sacrosidase) have been employed to de-
termine if they can clinically alleviate symptoms of
sucrase-isomaltase deficiency [22, 23].
Growing prevalence of sucrase-isomaltase
deficiency
A retrospective study assessed levels of disaccharidase
activity in mucosal biopsy tissue samples referred to a
large gastrointestinal specialty laboratory over a 6-year
period (N = 27,875) [27]. These specimens, most of
which were collected during pediatric endoscopies, re-
vealed at least one disaccharidase deficiency in 45 % of
samples. Among these, 21 % were sucrase deficient, indi-
cating that 9.3 % of the specimens showed low sucrase
activity.
Subsequently, a prospective pilot study assessed the
prevalence of disaccharidase abnormalities in children
with recurrent abdominal pain undergoing upper endos-
copy (esophagogastroduodenoscopy (EGD)) (N = 28).
Among them, 15 (53.6 %) had low lactase levels, 4
(14.3 %) had low sucrase levels, 5 (17.9 %) had low malt-
ase, and 4 (14.3 %) had low glucoamylase activity. Clinical
characteristics did not correlate with the degree of disac-
charidase deficiency [28]. More recently, a retrospective
review studied 963 symptomatic children undergoing
upper endoscopy and disaccharidase testing. Among
those, 73 (7.6 %) were sucrase deficient, defined as enzyme
activity <25 μmol/min/g. Only 4 children (5 %) had iso-
lated sucrase-isomaltase deficiency, with the others also
having lactase deficiency or pan-disaccharidase deficiency
when all enzymes were measured (n = 44; 60 %). Abnor-
mal biopsies were found in 33 children (45 %). Most had
abdominal pain (n = 49; 78 %) and/or diarrhea (n = 27;
43 %). The final diagnosis for these 73 patients is shown in
Fig. 1. It is important to note, however, that even though
disaccharidase deficiencies were found on biopsy, the at-
tending physician may not have accepted the deficiency as
the primary diagnosis [25].
Thus, there is still concern that the cited studies
underestimate the prevalence and only comprise a lim-
ited view of SID. In a study of 65 children diagnosed
with GSID, 53 reported the onset of symptoms before
1 year of age; however, only 17 were diagnosed by that
time and 30 were not diagnosed until 5 years of age [19].
While some are correctly diagnosed, many others may
be missed due to dietary elimination of high sucrose or
high starch foods as food allergies or misdiagnosed as
chronic nonspecific diarrhea or diarrhea-predominant ir-
ritable bowel syndrome. As a result, it is incumbent
upon us to more fully understand the clinical conse-
quences of SID. Population-based and well-controlled
studies are needed to explore the relationship of the
various genetic and secondary deficiencies and correlate
them with their clinical manifestations and response to
therapy.
Conclusions
Sucrase-isomaltase deficiency is more prevalent than pre-
viously suspected and often contributes to significant
symptoms for patients with either primary or secondary
Fig. 1 Primary diagnosis of symptomatic children undergoing upper endoscopy and disaccharidase testing. Final diagnosis on the visit after EGD
and disaccharidase testing among 73 children who were sucrase deficient (enzyme activity <25 μmol/min/g)
Cohen Molecular and Cellular Pediatrics  (2016) 3:5 Page 3 of 4
disease. Further research is required to correlate the geno-
type with a phenotype and to determine the appropriate
treatment algorithm for these patients.
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